Bovie Medical Corporation  

(Public, NYSEAMERICAN:BVX)   Watch this stock  
Find more results for BVX
+0.06 (1.91%)
Mar 16 - Close
NYSEAMERICAN real-time data - Disclaimer
Currency in USD
Range 3.09 - 3.20
52 week 1.87 - 4.29
Open 3.16
Vol / Avg. 114,402.00/81,112.00
Mkt cap 105.15M
P/E     -
Div/yield     -
EPS -0.17
Shares 33.02M
Beta -0.75
Inst. own 34%
May 14, 2018
Q1 2018 Bovie Medical Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Mar 12, 2018
Q4 2017 Bovie Medical Corp Earnings Call
Mar 12, 2018
Q4 2017 Bovie Medical Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '17) 2017
Net profit margin -8.99% -13.52%
Operating margin -9.59% -13.54%
EBITD margin - -7.83%
Return on average assets -13.26% -15.91%
Return on average equity -18.37% -21.79%
Employees 211 -
CDP Score - -


4 Manhattanville Rd Ste 106
PURCHASE, NY 10577-2119
United States - Map
+1-727-3842323 (Phone)
+1-631-4215821 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It operates through three segments: Core, OEM and J-Plasma. It is engaged in developing and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor's offices, surgery centers and hospitals around the world. It also develops J-Plasma, a helium-based plasma surgical product. The J-Plasma system consists of an electrosurgical generator unit, a handpiece and a supply of helium gas. Its products are marketed through brands, including Bovie, Aaron, DERM, IDS and ICON, and on a private label basis to distributors around the world. It offers its products in electrosurgery, cauteries and other products categories.

Officers and directors

Andrew Makrides Esq. Executive Chairman of the Board
Age: 75
Bio & Compensation  - Reuters
John Robert Saron President, Chief Sales and Marketing Officer, Director
Age: 64
Bio & Compensation  - Reuters
Charles Goodwin Chief Executive Officer, Director
Bio & Compensation  - Reuters
Jay D. Ewers Chief Financial Officer, Treasurer, Secretary
Age: 56
Bio & Compensation  - Reuters
Moshe Citronowicz Senior Vice President
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Craig A. Swandal Director
Age: 56
Bio & Compensation  - Reuters
John C. Andres Independent Director
Age: 59
Bio & Compensation  - Reuters
Michael E. Geraghty Independent Director
Age: 70
Bio & Compensation  - Reuters
Lawrence J. Waldman CPA Independent Director
Age: 71
Bio & Compensation  - Reuters